Augmentation of monocyte intracellular ascorbate in vitro protects cells from oxidative damage and inflammatory responses

Biochemical and Biophysical Research Communications

Volumn 345, Issue 3, 2006, Pages 1039-1043

  Loke, Wai Mun ^a,b   Proudfoot, Julie M ^a   McKinley, Allan J ^b   Croft, Kevin D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Ascorbic acid; F2 isoprostanes; Monocyte chemoattractant protein 1 (MCP 1); Monocytes; Oxidative stress; THP 1 cells; Vitamin C

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; BIOLOGICAL MARKER; ISOPROSTANE DERIVATIVE; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXY RADICAL; 2,2' AZOBIS(2 AMIDINOPROPANE); 2,2'-AZOBIS(2-AMIDINOPROPANE); AMIDINE; CCL2 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LIPID PEROXIDATION; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; CHEMISTRY; CULTURE TECHNIQUE; CYTOSOL; METABOLISM; METHODOLOGY; TIME;

AMIDINES; ASCORBIC ACID; CELL CULTURE TECHNIQUES; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; CHEMOKINE CCL2; CYTOSOL; F2-ISOPROSTANES; HUMANS; INFLAMMATION; MONOCYTES; OXIDATIVE STRESS; TIME FACTORS;

EID: 33746575765     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.04.174     Document Type: Article

References (34)

1. Stocker R., and Keaney Jr. J.F. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84 (2004) 1381-1449
2. Rosenfeld M.E. Oxidized LDL affects multiple atherogenic cellular responses. Circulation 83 (1991) 2137-2140
3. Charo I.F., and Taubman M.B. Chemokines in the pathogenesis of vascular disease. Circ. Res. 5 (2004) 858-866
4. Egashira K. Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1. Hypertension 41 (2003) 834-841
5. Deo R., Khera A., McGuire D.K., Murphy S.A., Meo Neto J.P., Morrow D.A., and Lemos J.A. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J. Am. Col. Cardiol. 44 (2004) 1812-1818
6. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
7. Nathan C. Points of control in inflammation. Nature 420 (2002) 846-852
8. Frei B. Ascorbic acid protects lipids in hHuman plasma and low-density lipoprotein against oxidative damage. Am. J. Clin. Nutr. 54 (1991) 1113-1118
9. Frei B., Stocker R., England L., and Ames B.N. Ascorbate: the most effective antioxidant in human blood plasma. Adv. Exp. Med. Biol. 264 (1990) 155-163
10. Yamamoto Y., Niki E., Eguchi J., Kamiya Y., and Shimasaki H. Oxidation of biological membranes and its inhibition, free radical chain oxidation of erythrocyte ghost membranes by oxygen. Biochim. Biophys. Acta 819 (1985) 29-36
11. Vanderlinde R.E. Measurement of total lactate dehydrogenase activity. Ann. Clin. Lab. Sci. 15 (1985) 13-31
12. Headlam H.A., and Davies M.J. Cell-mediated reduction of protein and peptide hydroperoxides to reactive free radicals. Free Rad. Biol. Med. 34 (2003) 44-55
13. Sauberlich H.E., Green M.D., and Omaye S.T. Determination of ascorbic acid and dehydroascorbic acid. In: Seib P.A., and Tolbert B.M. (Eds). Ascorbic acid: Chemistry, Metabolism, and Uses, 180th ACS National Meeting (1982), American Chemical Society, Washington, DC 199-221
14. Lykkesfeldt J., Loft S., and Poulsen H.E. Determination of ascorbic acid and dehydroascorbic acid in plasma by high-performance liquid chromatography with coulometric detection-are they reliable biomarkers of oxidative stress?. J. Anal. Biochem. 229 (1995) 329-335
15. Barja G., and Hernanz A. Vitamin C, dehydroascorbate, and uric acid in tissues and serum: high performance liquid chromatography. Methods Enzymol. 234 (1994) 331-337
16. Cohn R.G., Mirkovich A., Dunlap B., Burton P., Chiu S.H., Eugui E., and Caulfield J.P. Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines. Transplantation 68 (1999) 411-418
17. 2-isoprostanes using gas chromatography-mass spectrometry. Anal. Biochem. 268 (1999) 117-125
18. May J.M., Huang J., and Qu Z. Macrophage uptake and recycling of ascorbic acid: response to activation by lipopolysaccharide. Free Rad. Biol. Med. 39 (2005) 1449-1459
19. Levine M., Wang Y., Padayatty S.J., and Morrow J. A new recommended dietary allowance of Vitamin C for healthy young women. Proc. Natl. Acad. Sci. USA 98 (2001) 9842-9846
20. Halliwell B. Oxidative stress in cell culture: an under-appreciated problem?. Fed. Eur. Biochem. Soc. Lett. 540 (2003) 3-6
21. Cracowski J.L., Durand T., and Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol. Sci. 23 (2002) 360-366
22. Montine T.J., Montine K.S., Reich E.E., Terry E.S., Porter N.A., and Morrow J.D. Antioxidants significantly affect the formation of different classes of isoprostanes and neuroprostanes in rat cerebral synaptosomes. Biochem. Pharmacol. 65 (2003) 611-617
23. May J.M., Qu Z.C., and Morrow J.D. Interaction of ascorbate and α-tocopherol in resealed human erythrocyte ghosts. J. Biol. Chem. 271 (1996) 10577-10582
24. Packer J.E. Direct observation of a free radicali between Vitamin E and Vitamin C. Nature 278 (1979) 737-738
25. Bruno R.S., Leonard S.W., Atkinson J., Montine T.J., Ramakrishnan R., Bray T.M., and Traber M.G. Faster plasma Vitamin E disappearance in smokers is normalized by Vitamin C supplementation. Free Rad. Biol. Med. 40 (2006) 689-697
26. Pan J.P., Cheng T.M., Chou S.C., and Lai S.T. Vitamin C protects against lysophosphatidylcholine-induced expression of monocyte chemoattractant protein-1 in cultured human umbilical vein endothelial cells. J. Formos. Med. Assoc. 102 (2003) 151-157
27. Leonarduzzi G., Gamba P., Sottero B., Kadl A., Robbesyn F., Calogero R.A., Biasi F., Chiarpotto E., Leitinger N., Sevanian A., and Poli G. Oxysterol-induced up-regulation of mcp-1 expression and synthesis in macrophage cells. Free Rad. Biol. Med. 39 (2005) 1152-1161
28. Thurberg B.L., and Collins T. The nuclear factor-kb/ inhibitor of kb autoregulatory system and athersclerosis. Curr. Opin. Lipidol. 9 (1998) 387-396
29. Aukrust P., Berge R.K., Ueland T., Aaser E., Damås J.K., Wikeby L., Brunsvig A., Müller F., Forfang K., Frøland S.S., and Gullestad L. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. J. Am. Coll. Cardiol. 37 (2001) 485-491
30. 2-isoprostanes in plasma of smokers. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 7-13
31. 2-isoprostanes in plasma of nonsmokers exposed to environmental tobacco smoke. Nutr. Cancer 45 (2003) 176-184
32. Langlois M., Duprez D., Delanghe J., De Buyzere M., and Clement D.L. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 103 (2001) 1863-1868
33. Sánchez-Moreno C., Cano M.P., de Ancos B., Plaza L., Olmedilla B., Granado F., and Marti{dotless}́n A. Consumption of high-pressurized vegetable soup increases plasma Vitamin C and decreases oxidative stress and inflammatory biomarkers in healthy humans. J. Nutr. 134 (2004) 3021-3025
34. Gaut J.P., Belaaouaj A., Byyun J., Roberts II L.J., Maeda N., Frei B., and Heinecke J.W. Vitamin C fails to protect amino acids and lipids from oxidation during acute inflammation. Free Rad. Biol. Med. 40 (2006) 1494-1501